
Vascular device maker ev3 sold to Covidien for $2.6 billion
Another one bites the dust. After agreeing to sell itself to Covidien PLC for $2.6 billion, ev3 Inc. (NASDAQ: EVVV) becomes the third publicly traded Minnesota device firm to be acquired in just over a month. Dublin, Ireland-based Covidien agreed to pay $22.50 per share for ev3, a 19 percent premium over the vascular device […]